HCP & Product Marketing Specialist, SEA (Healthcare)

Location: Singapore, Singapore. Onsite work style with approximately 25–30% travel across Southeast Asia.

Company

hirify.global is a global healthcare technology company developing medical technologies intended to alleviate pain, restore health, and extend life.

What you will do

• Develop and execute product marketing plans for the MiniMed Diabetes portfolio across Southeast Asia.
• Lead launch readiness and commercialization activities for new products and portfolio innovations.
• Support portfolio positioning, value proposition development, therapy adoption, and lifecycle priorities.
• Develop healthcare professional engagement, scientific marketing, educational initiatives, congresses, workshops, and advisory activities.
• Partner with country commercial, Sales, Clinical, Training, Market Access, Medical, Supply Chain, Finance, and regional marketing teams.
• Track launch, adoption, portfolio, and commercial KPIs and prepare business reviews and decision-support materials for regional leadership.

Requirements

• Bachelor’s degree in Marketing, Business, Life Sciences, Healthcare, or Communications.
• Experience in product marketing, commercialization, product launches, portfolio marketing, or healthcare professional engagement.
• Ability to travel approximately 25–30% across Southeast Asia.
• Relevant marketing experience, with 2–5 years preferred.
• Experience working across commercial and cross-functional teams in a matrix organization.

Nice to have

• Experience in healthcare, medical devices, or pharmaceuticals.
• Regional or multi-country marketing experience across Southeast Asia.
• Experience supporting new product launches and developing healthcare professional engagement or educational programs.

Culture & Benefits

• Competitive salary and flexible benefits package.
• Benefits and resources designed to support employees across career and life stages.
• Work in a healthcare technology business focused on patient care and medical innovation.
• The Diabetes division is expected to transfer to MiniMed after required local legal and employment processes, subject to business needs and applicable requirements.